spinal anesthesia. complications of surgical and medical care, not elsewhere classified
Conditions
Interventions
Intervention 1: Group A: 2mg of Bupivacaine 0.5% hyperbaric was injected by 24 gaguge Quincke spinal needle in L4,L5 space in sitting position. Intervention 2: Group B: 5mg of Bupivacaine 0.5% hyperba
Treatment - Drugs
Group A: 2mg of Bupivacaine 0.5% hyperbaric was injected by 24 gaguge Quincke spinal needle in L4,L5 space in sitting position.
Group B: 5mg of Bupivacaine 0.5% hyperbaric was injected by 24 gaguge Quincke spinal needle in L4,L5 space in sitting position.
Sponsors
Private
Eligibility
Sex/Gender
All
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients who were candidate for elective anal surgeries with ASA I or II. Exclusion criteria: patients who had pain and did not answer to injecting 1cc of Fentanyl or the ones who their surgery took more than 15 min.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain degree. Timepoint: after performing spinal anesthesia and during surgery. Method of measurement: Mc-Gill quesionnaire and VAS method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ability to walk and finishing the block of S4 dermatom. Timepoint: after finishing the surgery. Method of measurement: VAS, clinician examination and direct interview with patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Khosro Farhadi
Kermanshah University of Medical Sciences
Outcome results
None listed